FI854839A - VACCIN ELLER DIAGNOSTIC PRODUCT ERHAOLLEN FRAON PEPTID, SAMT DAERI ANVAENDBAR POLYPEPTID. - Google Patents

VACCIN ELLER DIAGNOSTIC PRODUCT ERHAOLLEN FRAON PEPTID, SAMT DAERI ANVAENDBAR POLYPEPTID. Download PDF

Info

Publication number
FI854839A
FI854839A FI854839A FI854839A FI854839A FI 854839 A FI854839 A FI 854839A FI 854839 A FI854839 A FI 854839A FI 854839 A FI854839 A FI 854839A FI 854839 A FI854839 A FI 854839A
Authority
FI
Finland
Prior art keywords
erhaollen
daeri
anvaendbar
fraon
vaccin
Prior art date
Application number
FI854839A
Other languages
Finnish (fi)
Other versions
FI854839A0 (en
FI81452C (en
FI81452B (en
Inventor
Magdalene Y H So
Carolyn D Deal
Per O Hagblom
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of FI854839A publication Critical patent/FI854839A/en
Publication of FI854839A0 publication Critical patent/FI854839A0/en
Application granted granted Critical
Publication of FI81452B publication Critical patent/FI81452B/en
Publication of FI81452C publication Critical patent/FI81452C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention describes a polypeptide that is smaller than a naturally occurring gonococcal pilus protein but is capable of immunologically simulating a preserved antigen determinant position within a varying area in the carboxy terminal half of a gonococcal pilus protein, as well as vaccines, innocula, immunization methods and diagnostic tests using such a polypeptide, as well as antibodies produced by means of the polypeptides.
FI854839A 1984-04-06 1985-12-05 Diagnostic system for determining the pilus protein of Neisseria gono rrhoeae bacterium FI81452C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US59743484A 1984-04-06 1984-04-06
US59743484 1984-04-06
US8500565 1985-04-04
PCT/US1985/000565 WO1985004654A1 (en) 1984-04-06 1985-04-04 A peptide vaccine or diagnostic, and a polypeptide useful therefor

Publications (4)

Publication Number Publication Date
FI854839A true FI854839A (en) 1985-12-05
FI854839A0 FI854839A0 (en) 1985-12-05
FI81452B FI81452B (en) 1990-06-29
FI81452C FI81452C (en) 1990-10-10

Family

ID=24391484

Family Applications (1)

Application Number Title Priority Date Filing Date
FI854839A FI81452C (en) 1984-04-06 1985-12-05 Diagnostic system for determining the pilus protein of Neisseria gono rrhoeae bacterium

Country Status (9)

Country Link
EP (1) EP0177583A4 (en)
JP (1) JPS61501777A (en)
AU (1) AU582358B2 (en)
FI (1) FI81452C (en)
IL (1) IL74829A (en)
NO (1) NO854903L (en)
NZ (1) NZ211715A (en)
WO (1) WO1985004654A1 (en)
ZA (1) ZA852629B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4736017A (en) * 1984-04-30 1988-04-05 The Board Of Trustees Of The Leland Stanford Junior University Chemically defined vaccine against urinary infections
US4584195A (en) * 1984-06-21 1986-04-22 The Board Of Trustees Of The Leland Stanford Junior University Broad spectrum vaccine against gonorrhea
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
SE8601940D0 (en) * 1986-04-25 1986-04-25 Kabigen Ab PREPARATION OF FUSED PROTEINS, ANTIBODIES AND PROCESSES THEREFOR
WO1994008013A1 (en) * 1992-10-07 1994-04-14 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University Pilin variants and uses thereof
AU3968599A (en) * 1998-04-29 1999-11-16 American Cyanamid Company Vaccines containing recombinant pilin against Neisseria Gonorrhoeae or Neisseria Meningitidis
US7189405B1 (en) 1999-10-29 2007-03-13 Rice Peter A Peptide mimics of conserved gonococcal epitopes and methods and compositions using them

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186182A (en) * 1975-02-28 1980-01-29 Research Corporation Serological test for Neisseria gonorrhoeae antibodies
US4461838A (en) * 1975-04-25 1984-07-24 Bactex, Inc. Gonococcal Pili processes for the preparation thereof and the use thereof for the detection of and prevention of infections caused by Neisseria gonorrhoeae
US4188371A (en) * 1977-09-28 1980-02-12 Corning Glass Works Immunological detection of Neisseria bacteria via labelled antibodies
US4351761A (en) * 1978-05-15 1982-09-28 Research Corporation Purified antigen to test for Neisseria gonorrhoeae antibodies
US4241045A (en) * 1978-05-15 1980-12-23 Research Corporation Purified antigen to test for Neisseria gonorrheae antibodies
US4330623A (en) * 1980-02-19 1982-05-18 Merck & Co., Inc. Process for solubilization of gonococcal antigen
US4386066A (en) * 1981-08-20 1983-05-31 Merck & Co., Inc. Immunogenic complex from N. gonorrhoeae
US4497900A (en) * 1982-04-12 1985-02-05 Abbott Laboratories Immunoassay for Neisseria gonorrhoeae antigens

Also Published As

Publication number Publication date
FI854839A0 (en) 1985-12-05
IL74829A (en) 1989-02-28
AU4159085A (en) 1985-11-01
FI81452C (en) 1990-10-10
FI81452B (en) 1990-06-29
IL74829A0 (en) 1985-07-31
EP0177583A4 (en) 1988-06-08
AU582358B2 (en) 1989-03-23
WO1985004654A1 (en) 1985-10-24
ZA852629B (en) 1985-11-27
NO854903L (en) 1986-02-04
EP0177583A1 (en) 1986-04-16
JPS61501777A (en) 1986-08-21
NZ211715A (en) 1989-01-27

Similar Documents

Publication Publication Date Title
DE68924162D1 (en) STRESS PROTEINS AND USES THEREFOR.
NO950328L (en) Conjugates with weak immunogenic antigens and synthetic peptide carriers and vaccines containing them
WO1995029193A3 (en) Melanoma antigens
HUP0202796A2 (en) Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
NZ219113A (en) Hiv peptide containing epitope of the env protein
NO934801D0 (en) CTL4A receptor, fusion proteins containing it and its use
BR9306984A (en) Peptide antigen analog of a native peptide antigen vaccine antibody process to vaccinate a host in need of this treatment kit diagnostic processes to prepare an antigen analog of a native peptide antigen to prepare a vaccine to analyze a sample for a peptide antigen native and to analyze a sample for an antibody
TR199801722T2 (en) Peptide imm�nojenler.
YU152587A (en) MONOCLONE ANTIBODIES AND PEPTIDES USEFUL IN THE TREATMENT AND DIAGNOSIS OF HIV INFECTIONS
Jemmerson et al. Mapping antigenic sites on proteins: Implications for the design of synthetic vaccines.
HK1093314A1 (en) Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens
AU7752487A (en) Immunomodulating compositions and their use
DK461884D0 (en) PROTECTIVE PEPTID ANTIGEN
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
ATE382699T1 (en) METHOD FOR DESIGNING RECOMBITOPIC PEPTIDES
FI854839A (en) VACCIN ELLER DIAGNOSTIC PRODUCT ERHAOLLEN FRAON PEPTID, SAMT DAERI ANVAENDBAR POLYPEPTID.
ES2052370T3 (en) IMMUNOLOGICALLY ACTIVE PEPTIDES OR POLYPEPTIDES OF PARVOVIRUS B19.
ZA856655B (en) Cross-reactive and protective epitopes of circumsporozoite proteins
DK76191A (en) FILAMENTOEST HAEMAGGLUTININ FROM B.PERTUSSIS
WO2002051237A3 (en) Helicobacter proteins, nucleic acids and uses thereof
GB2314560A (en) Synthetic peptides of m. gallisepticum, antibodies thereto, their preparations and use
ES8800052A1 (en) Anaplasma marginale subunit antigen for vaccination and diagnosis.
DE69322960D1 (en) CONCEPTIBLE VACCINE
IL91609A0 (en) Allelic variants of plasmodium falciparum merozoite surface antigen
GB2244273A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SCRIPPS CLINIC AND RESEARCH FOUNDATION